Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Data for epilepsy treatment with levetiracetam are encouraging. Other additional data are described in Table 1. Future research to study levetiracetam as a frontline monotherapeutic agent is ...
Sky Harbour Group Corp. $13.70 0.83 6.45% ...
Warner Bros. Discovery Inc. Series A $10.37-0.64-5.81% ...
DAX Futures 22441.00-238.00-1.05% ...
DAX Futures 22681.00-206.00-0.90% ...
Inclusion criteria for this study were as follows as established previously (8): (1) modified Rankin Scale (mRS) score before onset: 0–2; (2) interval from onset or the final onset-free time: 6–24 h; ...
We would like to use cookies to collect information about how you use ons.gov.uk. We use this information to make the website work as well as possible and improve our services.
We would like to use cookies to collect information about how you use ons.gov.uk. We use this information to make the website work as well as possible and improve our services.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback